USNA
Usana Health Sciences Stock Analysis
AI Rating
- Quality7/10
- Growth↓ 0/10
- Value↑ 9/10
USNA Growth
- Revenue Y/Y↑ 8.28%
- EPS Y/Y↓ -73.64%
- FCF Y/Y↓ -75.62%
USNA Profitability
- Gross margin ↑ 78.30%
- EPS margin↓ 1.20%
- ROIC 5Y↑ 57.75%
USNA Risk
- Debt / Equity↓ 0.0
- Debt / FCF↓ 0.0
- Interest coverage↑ 49.5
Usana Health Sciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.